Anti-Human MyD88 Purified

Description: The polyclonal antibody reacts with human MyD88; the antibody was raised against residues 233-248 of human MyD88 and recognizes human antigens. MyD88, a myeloid differentiation primary response gene, is expressed in a variety of tissues and functions as an adapter molecule in the IL-1 signaling pathway involved in the inflammatory responses induced by cytokines and LPS. MyD88 associates with and recruits IRAK to the IL-1 receptor. Dominant negative mutants of MyD88 attenuate IL-1R-mediated NF-κB activation. MyD88 also functions as a regulator molecule for IL-18 receptor and human Toll receptor family. Targeted disruption of the MyD88 gene results in loss of cellular responses to IL-1 and IL-18, and MyD88-deficient mice lack responses to LPS. For applications with mouse MyD88, it is recommended that anti-human/mouse MyD88 (C-terminus) (cat. 14-6223) be used.

References:
Wang, Q., R. Dziarski, et al. 2001. Micrococci and peptidoglycan activate TLR2>MyD88>IRAK>TRAF>NIK>IKK>NF-kappaB signal transduction pathway that induces transcription of interleukin-8. Infect Immun 69: 2270-6.
Yang, R. B., M. R. Mark, et al. 1999. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J Immunol 163: 639-43.
Adachi, O., T. Kawai, et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-50.
Hardiman, G., F. L. Rock, et al. 1996. Molecular characterization and modular analysis of human MyD88. Oncogene 13: 2467-75.
Hultmark, D. 1994. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem Biophys Res Commun 199: 144-6.
Lord, K. A., B. Hoffman-Liebermann, et al. 1990. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5: 1095-7.
Akira, S., K. Takeda, et al. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-80.